comparemela.com

Page 3 - Luk Vandenberghe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AstraZeneca, Sputnik vaccines face hurdles if COVID-19 shots become annual affair

FOCUS-AstraZeneca, Sputnik vaccines face hurdles if COVID

Astra, Sputnik vaccines face hurdles if Covid shots become annual affair

Astra, Sputnik vaccines face hurdles if Covid shots become annual affair
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Affinia Therapeutics Announces Addition of Gene Therapy Scientific and Medical Experts to Leadership Team to Advance Novel Gene Therapy Platform and Programs to the Clinic

Home / Top News / Affinia Therapeutics Announces Addition of Gene Therapy Scientific and Medical Experts to Leadership Team to Advance Novel Gene Therapy Platform and Programs to the Clinic Affinia Therapeutics Announces Addition of Gene Therapy Scientific and Medical Experts to Leadership Team to Advance Novel Gene Therapy Platform and Programs to the Clinic Gene editing expert Charles Albright, Ph.D., joins as chief scientific officer Gene therapy development expert Petra Kaufmann, M.D.,  joins as chief medical officer – WALTHAM, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies for rare and non-rare diseases, today announced the completion of its leadership team. Collectively, the executives represent a diverse team of proven leaders in gene therapy who have successfully developed novel platforms and translated the

US COVID-19 Vaccine Hopeful Of Using Gates Foundation Cash To Prepare For Human Trial

US COVID-19 Vaccine Hopeful Of Using Gates Foundation Cash To Prepare For Human Trial US COVID-19 Vaccine Hopeful Of Using Gates Foundation Cash To Prepare For Human Trial Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson said primate safety and efficacy tests have proven promising for their single-dose candidate, targeted for room-temperature storage. Gates Foundation money will support pre-clinical tests ahead of overseas safety trial (Representational) Zurich: Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their COVID-19 vaccine candidate toward 2021 human trials.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.